Episodes of Microbial Keratitis With Therapeutic Silicone Hydrogel Bandage Soft Contact LensesSaini, Arvind M.D., M.B.A.; Rapuano, Christopher J. M.D.; Laibson, Peter R. M.D.; Cohen, Elisabeth J. M.D.; Hammersmith, Kristin M. M.D. Erratum In the article on page 324 of volume 39, issue 5, there are some errors in the text. The Abstract Results section should be replaced with the text “Seventy-four patients were treated with a therapeutic SiH BSCL (102 intervals of use) for complicated ocular surface disease. Two patients developed infectious corneal infiltrates (2/102, 2.0%).” In the article text, Methods section, the first sentence of the 2nd paragraph should read as follows “Our primary outcome measure was infection while wearing a BSCL, which was defined as suspected MK.” Finally, on page 325, Results section, the last sentence of the 5th paragraph should read as follows “Although 1 patient had LSCD (1/11 intervals, 9.1%, P=0.41) and the other RES (1/3 intervals, 33.3%, P=0.12), there was no statistically significant incidence of infection based on disease state.” Eye & Contact Lens. 39(6):415, November 2013. Eye & Contact Lens: September 2013 - Volume 39 - Issue 5 - p 324–328 doi: 10.1097/ICL.0b013e31829fadde Article Abstract Author Information Objective: To report the therapeutic practice patterns of silicone hydrogel (SiH) bandage soft contact lenses (BSCL) and the resultant rate of microbial keratitis (MK). Methods: A retrospective case series of patients treated with therapeutic BSCLs for ocular surface disease from January 2006 to January 2009 in a tertiary care cornea practice. All patients had a history of ocular surface disease. Results: Seventy-four patients were treated with a therapeutic SiH BSCL (102 intervals of use) for complicated ocular surface disease. Two patients developed infectious corneal infiltrates (3/103, 2.9%). Two of 3 MK episodes were in patients with limbal stem-cell deficiency (2/102, 2.0%). Conclusions: Therapeutic SiH BSCLs were safely used in most patients. However, results suggest that prophylactic antibiotic use did not eliminate the risk for MK with SiH BSCL use in patients with chronic ocular surface disease. Cornea Service (A.S., C.J.R., P.R.L., K.M.H.), Wills Eye Institute, Philadelphia, PA; and Department of Ophthalmology (E.J.C.), New York University, New York, NY. Address correspondence to Arvind Saini, M.D., M.B.A.; e-mail: email@example.com The authors have no funding or conflicts of interest to disclose. Accepted June 9, 2013 © 2013 Contact Lens Association of Ophthalmologists, Inc.